TAG-1 A2

TAG-1 A2 is a peptide variant designed to study antigen presentation and MHC-binding preferences. The sequence includes anchor residues contributing to peptide-MHC stability and conformational integrity. Researchers use it to examine epitope positioning, solvent exposure, and structural determinants of recognition. Its defined motif supports immunological and biophysical analysis.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: ta-529

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
Sequence
SLGWLFLLL
Areas of Interest
Antigen-presenting Cells; Cancer Research

TAG-1 A2 is a synthetic peptide compound designed for advanced biochemical research, particularly within the domains of cell adhesion, neural development, and molecular interaction studies. As a peptide derivative of the neural cell adhesion molecule TAG-1 (Transient Axonal Glycoprotein-1, also known as Contactin-2), TAG-1 A2 embodies a critical segment of the protein, allowing researchers to dissect its functional roles in axonal guidance and cell-cell communication. The compound's utility stems from its ability to mimic or competitively inhibit endogenous TAG-1 interactions, thereby facilitating the exploration of signal transduction pathways and protein-protein interaction networks in neural and developmental biology. Its carefully defined sequence and biochemical properties make it a valuable tool for both in vitro and in vivo experimental systems.

Neuroscience research: TAG-1 A2 is frequently employed in neuroscience to study the molecular underpinnings of neural development and axonal pathfinding. By serving as a functional analog or antagonist of native TAG-1, the peptide enables the dissection of mechanisms underlying neuronal migration, fasciculation, and synaptic targeting. Researchers utilize it to map the pathways involved in the formation of neural circuits, providing insight into the roles of cell adhesion molecules in nervous system organization and plasticity.

Protein-protein interaction analysis: The unique sequence of TAG-1 A2 facilitates targeted investigations into the binding affinities and specificities between TAG-1 and its physiological partners, such as L1-CAM, NrCAM, and other immunoglobulin superfamily members. Through peptide-based interaction assays, surface plasmon resonance, or pull-down experiments, scientists can quantitatively assess how alterations in the TAG-1 domain affect intermolecular recognition, thereby advancing understanding of adhesion molecule networks in cellular environments.

Peptide inhibitor studies: As a designed peptide fragment, TAG-1 A2 is instrumental in competitive inhibition assays that probe the functional consequences of disrupting TAG-1-mediated signaling. By selectively interfering with endogenous protein interactions, the compound allows for the evaluation of downstream effects on cellular morphology, motility, and differentiation. Such studies are essential for elucidating the regulatory checkpoints that govern cell adhesion and migration during embryogenesis and tissue patterning.

Cell culture modeling: In vitro systems benefit from the application of TAG-1 A2 to modulate cell adhesion dynamics and simulate aspects of the neural microenvironment. Researchers introduce the peptide into neuronal or glial cell cultures to investigate how perturbations in TAG-1 signaling impact cell aggregation, neurite extension, and synaptogenesis. These models are critical for testing hypotheses related to neurodevelopmental processes and for optimizing conditions in neural tissue engineering.

Peptide-based assay development: The defined structure of TAG-1 A2 supports its use in the creation and validation of biochemical assays that monitor cell adhesion, receptor-ligand interactions, or signal transduction events. By incorporating the peptide into ELISA formats, biosensor platforms, or high-throughput screening protocols, laboratories can develop robust and reproducible methods for quantifying TAG-1 activity, screening for modulators, or characterizing the effects of experimental interventions on neural adhesion pathways.

Source#
Homo sapiens (human)
Epitope
78-86
Restricting HLA
HLA-A2
References
Adair; J Immunother 2008

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide CDMOCustom Conjugation ServicePeptide Modification ServicesPeptide Synthesis ServicescGMP Peptide ServicePeptide Nucleic Acids SynthesisEpitope Mapping ServicesPeptide Analysis Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers